Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? a randomized-controlled study

Angiology

Volumn 62, Issue 3, 2011, Pages 225-230

  Sadat, Umar ^a,b   Walsh, Stewart R ^a   Norden, Anthony G ^a   Gillard, Jonathan H ^a   Boyle, Jonathan R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

contrast induced nephropathy; kidney; N acetylcysteine; nephroprotection

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; CREATININE; RETINOL BINDING PROTEIN;

AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYDRATION; KIDNEY INJURY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; AGED; ALBUMINURIA; ANGIOGRAPHY; BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PERIPHERAL ARTERIAL DISEASE; RETINOL-BINDING PROTEINS, CELLULAR; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 79952802526     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710377078     Document Type: Article

References (26)

1. Barrett BJ, Parfrey PS Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994 ; 331 (21). 1449-1450. (Pubitemid 24348362)
2. Kolonko A., Kokot F., Wiecek A. Contrast-associated nephropathy-old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant. 1998 ; 13 (3). 803-806. (Pubitemid 28119084)
3. Tublin ME, Murphy ME, Tessler FN Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol. 1998 ; 171 (4). 933-939. (Pubitemid 28449948)
4. Carbonell N., Blasco M., Sanjuan R., et al. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. Int J Cardiol. 2007 ; 115 (1). 57-62. (Pubitemid 44855192)
5. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000 ; 343 (3). 180-184. (Pubitemid 30489215)
6. Stenstrom DA, Muldoon LL, Armijo-Medina H., et al. N-Acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials. J Vasc Interv Radiol. 2008 ; 19 (3). 309-318. (Pubitemid 351273624)
7. Rashid ST, Salman M., Myint F., et al. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. J Vasc Surg. 2004 ; 40 (6). 1136-1141. (Pubitemid 40037281)
8. Kotlyar E., Keogh AM, Thavapalachandran S., et al. Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures-a randomised controlled trial. Heart Lung Circ. 2005 ; 14 (4). 245-251. (Pubitemid 43055999)
9. Moore NN, Lapsley M., Norden AG, et al. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. J Endovasc Ther. 2006 ; 13 (5). 660-666. (Pubitemid 44749197)
10. Paraskevas KI, Giannoukas AD, Mikhailidis DP The impact of impaired renal function on long-term outcomes in patients with peripheral arterial disease. Angiology. 2010 ; 61 (4). 415-416.
11. Paraskevas KI, Giannoukas AD, Mikhailidis DP Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg. 2009 ; 23 (5). 690-699.
12. O'Hare AM, Bertenthal D., Shlipak MG, Sen S., Chren MM Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005 ; 16 (2). 514-519. (Pubitemid 41725149)
13. Bernard AM, Vyskocil AA, Mahieu P., Lauwerys RR Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem. 1987 ; 33 (6). 775-779.
14. Lapsley M., Akers K., Norden AG Sensitive assays for urinary retinol-binding protein and beta-2-glycoprotein-1 based on commercially available standards. Ann Clin Biochem. 1998 ; 35 (pt 1). 115-119. (Pubitemid 28043635)
15. McCullough PA Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008 ; 51 (15). 1419-1428. (Pubitemid 351471786)
16. Fung JW, Szeto CC, Chan WW, et al. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. Am J Kidney Dis. 2004 ; 43 (5). 801-808. (Pubitemid 38529617)
17. Baskurt M., Okcun B., Abaci O., et al. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy. Eur J Clin Invest. 2009 ; 39 (9). 793-799.
18. Alnaeb ME, Youssef F., Mikhailidis DP, Hamilton G. Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. Angiology. 2006 ; 57 (1). 65-71.
19. Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 ; 1 (3). 200-208. (Pubitemid 352831522)
20. Fliser D., Novak J., Thongboonkerd V., et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007 ; 18 (4). 1057-1071. (Pubitemid 46536892)
21. Rifai N., Gillette MA, Carr SA Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006 ; 24 (8). 971-983. (Pubitemid 44215392)
22. Hoffmann U., Fischereder M., Kruger B., Drobnik W., Kramer BK The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004 ; 15 (2). 407-410. (Pubitemid 38140781)
23. Morcos SK Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media? Clin Radiol. 2009 ; 64 (5). 468-472.
24. Al-Ghonaim M., Pannu N. Prevention and treatment of contrast-induced nephropathy. Tech Vasc Interv Radiol. 2006 ; 9 (2). 42-49. (Pubitemid 46670027)
25. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002 ; 40 (8). 1383-1388. (Pubitemid 35192860)
26. Kay J., Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. 2003 ; 289 (5). 553-558. (Pubitemid 37428626)